Zydus Lifesciences Limited (ZYDUSLIFE.NS)

947.40 -3.85 (-0.40%) At close: 03:30PM IST

Zydus Lifesciences Limited

Zydus Corporate Park
Scheme No. 63 Survey No. 536, Khoraj (Gandhinagar) Nr. Vaishnodevi Circle, S. G. Highway
Ahmedabad 382481
India
91 79 7180 0000
https://www.zyduslife.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 23,026

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Sharvil Pankajbhai Patel	MD & Executive Director	262.5M	N/A	1979
Dr. Ganesh Narayan Nayak	COO & Executive Director	120M	N/A	1955
Mr. Punit Patel	President & CEO of America	N/A	N/A	N/A
Mr. Nitinkumar Dalsukhray Parekh	Chief Financial Officer	54.31M	N/A	N/A
Mr. Arvind Bothra	Head of Investor Relations	N/A	N/A	N/A
Mr. Dhaval Narendra Soni	Company Secretary & Compliance Officer	2.09M	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.

Description

Zydus Lifesciences Limited engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, and internationally. It operates through Pharmaceuticals and Consumer Products segments. It offers finished dosage human formulations comprising generics, branded generics, and specialty formulations, including biosimilars and vaccines; active pharmaceutical ingredients; consumer wellness products; and products in the therapeutic areas of pain management, neurology, metabolic disorder, and liver diseases. The company offers the products under the Everyuth and Nutralite, Complan, Glucon D, and Nycil brands. In addition, the company offers a pipeline of biological products in the areas of oncology, autoimmune disease, nephrology, inflammation, rheumatology, hepatology, and infectious illnesses. Further, it engages in the investment, animal health and veterinary, pharmacy retail, and manpower supply and administration activities. The company was formerly known as Cadila Healthcare Limited and changed its name to Zydus Lifesciences Limited in February 2022. Zydus Lifesciences Limited was founded in 1952 and is headquartered in Ahmedabad, India.

Corporate governance

Zydus Lifesciences Limited’s ISS governance QualityScore as of 1 April 2024 is 5. The pillar scores are Audit: 8; Board: 4; Shareholder rights: 9; Compensation: 5.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.